BIOCONNSE

Biocon in the news

Made the news 2 times since we started tracking. Newest first.

• 21 Sep 2026RegulatoryPertuzumab biosimilar gets a positive opinion from Europe's CHMPIt is the first biosimilar recommended under a new tailored clinical approach.
• 8 Sep 2026OrdersWins a 10-year supply contract for Pertuzumab in BrazilThe contract covers supply of Pertuzumab in Brazil over 10 years.